Sermorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH 1–29). It has been studied for its ability to stimulate the pituitary gland to release growth hormone and for its effects on growth hormone signaling, IGF-1 production, metabolism, body composition, and endocrine function.
Sermorelin has been used historically in clinical settings, but currently marketed research formulations should not be considered equivalent to an FDA-approved drug product. Its safety, purity, and effectiveness depend on the specific formulation and intended use.
For Research Use Only. Not for Human Consumption.
This product is intended strictly for laboratory and scientific research purposes and is not intended to diagnose, treat, cure, or prevent any disease.
Sermorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH 1–29). It has been studied for its ability to stimulate the pituitary gland to release growth hormone and for its effects on growth hormone signaling, IGF-1 production, metabolism, body composition, and endocrine function.
Sermorelin has been used historically in clinical settings, but currently marketed research formulations should not be considered equivalent to an FDA-approved drug product. Its safety, purity, and effectiveness depend on the specific formulation and intended use.
For Research Use Only. Not for Human Consumption.
This product is intended strictly for laboratory and scientific research purposes and is not intended to diagnose, treat, cure, or prevent any disease.